Reckitt Benckiser Plc May Sell Pharmaceuticals Business

Published: Oct 22, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Reckitt Benckiser may sell its pharmaceuticals unit, which has been suffering from declining sales of its main heroin addiction drug, to focus on growing consumer health and household cleaning products businesses. The British consumer goods group said on Tuesday it was reviewing options for the pharmaceuticals business, which analysts said could fetch over 2 billion pounds ($3.2 billion) and appeal to international drugmakers. It also beat third-quarter sales forecasts and nudged up its full-year outlook, signaling it was navigating a slowdown in emerging markets that has hurt rival Unilever.

Help employers find you! Check out all the jobs and post your resume.

Back to news